FourThought Financial Partners LLC Has $1.22 Million Holdings in Progyny, Inc. (NASDAQ:PGNY)

FourThought Financial Partners LLC raised its stake in shares of Progyny, Inc. (NASDAQ:PGNY) by 1.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 32,683 shares of the company’s stock after purchasing an additional 423 shares during the period. FourThought Financial Partners LLC’s holdings in Progyny were worth $1,215,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in PGNY. International Assets Investment Management LLC lifted its position in shares of Progyny by 352,414.2% during the fourth quarter. International Assets Investment Management LLC now owns 5,876,411 shares of the company’s stock valued at $218,485,000 after purchasing an additional 5,874,744 shares in the last quarter. Vanguard Group Inc. lifted its position in shares of Progyny by 7.4% during the 3rd quarter. Vanguard Group Inc. now owns 8,157,604 shares of the company’s stock worth $277,522,000 after buying an additional 565,160 shares in the last quarter. Jennison Associates LLC boosted its stake in shares of Progyny by 19.4% in the 3rd quarter. Jennison Associates LLC now owns 2,706,454 shares of the company’s stock worth $92,074,000 after buying an additional 438,932 shares during the last quarter. Invesco Ltd. grew its holdings in shares of Progyny by 67.0% in the third quarter. Invesco Ltd. now owns 888,427 shares of the company’s stock valued at $30,224,000 after acquiring an additional 356,529 shares in the last quarter. Finally, Fort Washington Investment Advisors Inc. OH increased its position in shares of Progyny by 58.1% during the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 688,020 shares of the company’s stock valued at $25,581,000 after acquiring an additional 252,910 shares during the last quarter. 94.93% of the stock is owned by institutional investors.

Progyny Stock Performance

PGNY stock traded down $0.35 during midday trading on Friday, reaching $31.72. 760,486 shares of the company’s stock traded hands, compared to its average volume of 683,382. The firm has a market capitalization of $3.05 billion, a PE ratio of 51.16, a price-to-earnings-growth ratio of 1.31 and a beta of 1.51. The company has a 50-day moving average price of $35.10 and a two-hundred day moving average price of $35.60. Progyny, Inc. has a 52 week low of $29.44 and a 52 week high of $44.95.

Progyny (NASDAQ:PGNY) last released its quarterly earnings data on Tuesday, February 27th. The company reported $0.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.09 by $0.04. Progyny had a return on equity of 12.64% and a net margin of 5.70%. The company had revenue of $269.94 million for the quarter, compared to analyst estimates of $274.08 million. During the same period in the previous year, the company posted $0.03 EPS. The firm’s revenue for the quarter was up 26.0% compared to the same quarter last year. As a group, analysts predict that Progyny, Inc. will post 0.7 EPS for the current fiscal year.

Insider Activity

In related news, President Michael E. Sturmer sold 2,260 shares of the business’s stock in a transaction dated Tuesday, February 6th. The stock was sold at an average price of $40.00, for a total transaction of $90,400.00. Following the completion of the transaction, the president now directly owns 158,532 shares in the company, valued at $6,341,280. The transaction was disclosed in a document filed with the SEC, which is available through this link. In related news, President Michael E. Sturmer sold 2,260 shares of the firm’s stock in a transaction that occurred on Tuesday, February 6th. The shares were sold at an average price of $40.00, for a total value of $90,400.00. Following the sale, the president now directly owns 158,532 shares of the company’s stock, valued at $6,341,280. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, President Michael E. Sturmer sold 4,515 shares of Progyny stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $31.95, for a total transaction of $144,254.25. Following the sale, the president now owns 380,038 shares of the company’s stock, valued at $12,142,214.10. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 125,030 shares of company stock worth $4,714,385. 12.30% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on PGNY shares. Leerink Partnrs reissued an “outperform” rating on shares of Progyny in a research report on Monday, February 26th. Truist Financial restated a “buy” rating and set a $46.00 price objective on shares of Progyny in a report on Wednesday, April 17th. SVB Leerink started coverage on shares of Progyny in a research note on Monday, February 26th. They issued an “outperform” rating and a $49.00 target price on the stock. KeyCorp decreased their price target on shares of Progyny from $45.00 to $43.00 and set an “overweight” rating for the company in a research note on Wednesday, February 28th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $48.00 price objective on shares of Progyny in a research note on Wednesday, February 28th. Ten equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $48.30.

Progyny Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.